Congressional Trader
Live

ALB congressional trades

7 matched disclosures

Track congressional trades for ALB
Tracked disclosures
7
Lawmakers
4
Buy / sell
2 / 5
Avg post-trade move
N/A
Latest filing 2026-06-16

ALB congressional trades snapshot

This page summarizes public STOCK Act disclosures involving ALB. It is useful for seeing which lawmakers reported ALB transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.

Last updated

Jun 16, 2026

Data source

Public House and Senate STOCK Act disclosures normalized by Congressional Trader.

Key caveat

Filing date can trail transaction date. This page is for research and monitoring, not investment advice.

What the ALB congressional trade page shows

Congressional Trader tracks 7 public STOCK Act disclosures for ALBacross 4 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.

The most recent ALB filing shown here was filed on Jun 16, 2026 by John Boozman as a purchase. Related lawmakers include Jefferson Shreve, Rick W. Allen, John Boozman, Julie Johnson.

Pro performance summary

Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.

Compare Pro plans
John BoozmanR-ARSenate
No committee data
Filed Jun 16, 2026
Delay 32 days
View filing
ALBNotable
Albemarle Corporation Common Stock
Purchase
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Jun 22, 2025
Delay 41 days
View filing
ALBNotable
Albemarle Corporation Common
Sale
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed May 8, 2025
Delay 31 days
View filing
ALBNotable
Albemarle Corporation Common Stock
Purchase
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Julie JohnsonD-TXHouse
No committee data
Filed Mar 12, 2025
Delay 28 days
View filing
Albemarle Corporation Common
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
No committee data
Filed Mar 9, 2025
Delay 13 days
View filing
ALBNotable
Albemarle Corporation Common
Sale
$15K - $50K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Rick W. AllenR-GAHouse
No committee data
Filed Jan 11, 2024
Delay 21 days
View filing
ALBNotable
Albemarle Corporation
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade
Rick W. AllenR-GAHouse
No committee data
Filed Jan 11, 2024
Delay 21 days
View filing
Albemarle Corporation
Sale
$1K - $15K
Expert AnalysisPro
/ 100 Political Alpha

Upgrade to see committee overlap, performance context, and full expert analysis.

Buy price
Return since trade
Follow $10K gain
Expert analysis is Pro-only
Upgrade

FAQ

Which lawmakers traded ALB?

Recent ALB disclosures include Jefferson Shreve, Rick W. Allen, John Boozman, Julie Johnson.

What is the buy/sell mix for ALB?

The visible sample currently shows 2 purchases and 5 sales or partial sales.

Should I trade based on ALB disclosures?

No. This page summarizes public filings for research and monitoring. It is not investment advice.